O2 Muu julkaisu
Correction to: Cost‑effectiveness analysis of stand‑alone or combined non‑invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study (The European Journal of Health Economics, (2019), 20, 9, (1437-1449), 10.1007/s10198-019-01096-5)
Tekijät: Lorenzoni V., Bellelli S., Caselli C., Knuuti J., Underwood S.R., Neglia D., Turchetti G., Pietila M., Mäki M., Teresinska A., Aguadé-Bruix S., Pizzi M.N., Todiere G., Gimelli A., Lombardi M., Puzzuoli S., Mangione M., Marcheschi P., Schroeder S., Drosch T., Poddighe R., Casolo G., Anagnostopoulos C., Pugliese F., Rouzet F., Le Guludec D., Cappelli F., Valente S., Gensini G.F., Zawaideh C., Capitanio S., Sambuceti G., Marsico F., Filardi P.P., Fernández-Golfín C., Rincón L.M., Zamorano J.L., Graner F.P., Nekolla S., de Graaf M.A., Scholte A.J.H.A., Fiechter M., Stehli J., Gaemperli O., Kaufmann P.A., Reyes E., Nkomo S., Carpeggiani C., Giannessi D., Mariani F., Marinelli M., Sicari R.
Kustantaja: Springer Verlag
Julkaisuvuosi: 2019
Journal: European Journal of Health Economics
Tietokannassa oleva lehden nimi: European Journal of Health Economics
Vuosikerta: 20
Numero: 9
Aloitussivu: 1451
Sivujen määrä: 1
ISSN: 1618-7598
DOI: https://doi.org/10.1007/s10198-019-01128-0
In the Published article, the value in the abstract has been published incorrectly. The correct abstract section is as follows:
Abstract
Aim This study aimed at evaluating the cost
effectiveness of different non-invasive imaging-guided strategies for
the diagnosis of obstructive coronary artery disease (CAD) in a European
population of patients from the Evaluation of Integrated Cardiac
Imaging in Ischemic Heart Disease (EVINCI) study.
Methods and results
Cost-effectiveness analysis was performed in 350 patients (209 males,
mean age 59 ± 9 years) with symptoms of suspected stable CAD undergoing
computed tomography coronary angiography (CTCA) and at least one cardiac
imaging stress test prior to invasive coronary angiography (ICA) and in
whom imaging exams were analysed at dedicated core laboratories.
Stand-alone stress tests or combined non-invasive strategies, when the
first exam was uncertain, were compared. The diagnostic end point was
obstructive CAD defined as > 50% stenosis at quantitative ICA in the
left main or at least one major coronary vessel. Effectiveness was
defined as the percentage of correct diagnosis (cd) and costs were
calculated using country-specific reimbursements. Incremental
cost-effectiveness ratios (ICERs) were obtained using per-patient data
and considering “no-imaging” as reference. The overall prevalence of
obstructive CAD was 28%. Strategies combining CTCA followed by stress
ECHO, SPECT, PET, or stress CMR followed by CTCA were all cost
effective. ICERs values indicated cost saving from − 969€/cd for
CMR-CTCA to − 1490€/cd for CTCA-PET, − 3092€/cd for CTCA-SPECT and
− 3776€/cd for CTCA-ECHO, similarly when considering early
revascularization as effectiveness measure.
Conclusion In
patients with suspected stable CAD and low prevalence of disease,
combined non-invasive strategies with CTCA and stress imaging are cost
effective as gatekeepers to ICA and to select candidates for early
revascularization.
The original article has been updated.
